Phase IIa clinical trial evaluating dendritic cell vaccine for the treatment of low-grade gliomas

Authors
Category Primary study
JournalNeuro-Oncology
Year 2016
This article has no abstract
Epistemonikos ID: 32eeae55bb43c958767a936d27b0f94c50817350
First added on: Dec 20, 2022